Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27395852 | 0.70 | — | — | |
| SCHEMBL8851480 | 0.69 | — | — | |
| SCHEMBL715610 | 0.69 | — | — | |
| SCHEMBL345296 | 0.69 | — | — | |
| SCHEMBL27515627 | 0.69 | TSHR (0.38) | TSHRALDH1A1TDP1 | |
| SCHEMBL2229470 | 0.68 | TSHR (0.39) | TSHRGBA1ALDH1A1TDP1 | |
| SCHEMBL14316348 | 0.67 | — | — | |
| SCHEMBL2639167 | 0.67 | — | — | |
| SCHEMBL97294 | 0.67 | — | — | |
| SCHEMBL12677768 | 0.67 | TSHR (0.42) | TSHRCYP3A4ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084108-A1 | SILYLATING GRAFTING AGENTS, POLYMERS GRAFTED THEREWITH AND METHODS OF SYNTHESIS | BRIDGESTONE CORPORATION (JP) | 2025-03-13 | — | — | US | disclosed |
| US-20250084190-A1 | COMPOSITIONS INCLUDING FUNCTIONALIZED SILYLATED POLYMERS, CURED COMPOSITIONS AND METHODS | BRIDGESTONE CORPORATION (JP) | 2025-03-13 | — | — | US | disclosed |
| WO-2023130006-A1 | SILYLATING GRAFTING AGENTS, POLYMERS GRAFTED THEREWITH AND METHODS OF SYNTHESIS | BRIDGESTONE CORPORATION (JP) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023130005-A1 | COMPOSITIONS INCLUDING FUNCTIONALIZED SILYLATED POLYMERS, CURED COMPOSITIONS AND METHODS | BRIDGESTONE CORPORATION (JP) | 2023-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084108-A1 | SILYLATING GRAFTING AGENTS, POLYMERS GRAFTED THEREWITH AND METHODS OF SYNTHESIS | ILK, MSN, ALG8 | TSHR 4519/4885GBA1 1172/4885CYP3A4 3677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.